疣治疗市场基于(关键地区、市场参与者、规模和份额)- 到 2031 年的预测

  • Report Code : TIPRE00024332
  • Category : Pharmaceuticals
  • Status : Published
  • No. of Pages : 401
Buy Now

2021 年疣治疗市场价值为 18.2954 亿美元,预计 2021 年至 2028 年复合年增长率为 3.4%。

疣治疗市场的增长归因于人乳头瘤病毒感染的流行和尖锐湿疣的复发以及新产品的开发。然而,低收入国家的诊断状况不佳限制了市场增长。疣是由人乳头瘤病毒 (HPV) 引起的皮肤生长。 HPV 有 60 多种类型,其中几种可能会导致皮肤出现疣。尽管局部治疗可能会在几周内解决疣问题,并且副作用最小,但它们可能不会一直有效。因此,液氮冷冻疗法是一种合适的治疗选择,其治愈率为 60-90%,复发率低于 10-20%。

在美国,由于疣治疗程序的需求减少了对 COVID-19 的关注重点发生了转变。这场大流行病给全球供应链、消费市场和整个经济造成了严重破坏。由于世界各国政府采取的措施对疣治疗市场的增长产生了负面影响。

疣治疗市场利润丰厚的地区


市场洞察
人乳头瘤病毒感染流行率上升和生殖器疣复发推动疣治疗市场增长
疣是由多种人乳头瘤病毒(HPV)毒株引起的,不同毒株会导致身体不同部位出现疣。健康人接触疣可能会受到感染。根据美国疾病控制与预防中心 (CDC) 的数据,2018 年,美国约有 20% 的人口,即约 4250 万人患有性传播感染 (STI)。此外,在接种 HPV 疫苗之前,美国每年约有 340,000 至 360,000 名女性和男性受到尖锐湿疣的影响。而且,尖锐湿疣的复发率很高。根据国家生物技术信息中心 (NCBI) 的数据,全球约 30% 的疣病例预计会在感染后的前四个月内消退。此外,HPV感染会导致宫颈癌,而宫颈癌是全球女性第四大常见癌症。根据世界卫生组织 (WHO) 的数据,2018 年记录了约 570,000 例新发宫颈癌病例,低收入国家的患病率很高。因此,HPV 感染患病率的增加导致疣病例增加,而疣的高复发率正在推动疣治疗市场的增长。

基于类型的见解
基于类型,疣治疗市场进一步细分为寻常疣、生殖器疣、扁平疣等。寻常疣细分市场占有最大的市场份额。然而,预计 2021 年和 2028 年尖锐湿疣领域的复合年增长率最高。尖锐湿疣是指通常由 HPV 引起的性传播感染。性传播疾病的患病率不断上升,以及开发生殖器疣治疗方案的研究和开发工作不断增加,将推动未来几年该细分市场的增长。

疣治疗市场(按类型) 2021 年和 2028 年

基于治疗的见解
基于治疗,疣治疗市场进一步细分为物理破坏、免疫调节和化学破坏。物理破坏市场进一步细分为冷冻疗法、手术切除和激光治疗。免疫调节又分为干扰素、类维生素A和锌。化学破坏部分又分为博来霉素、斑蝥素、水杨酸等。物理破坏领域在疣治疗市场中占有最大份额,预计在预测期内将实现市场上最高的复合年增长率。

基于最终用户的见解
基于最终用户,疣治疗治疗市场分为医院、家庭护理、专科诊所等。医院细分市场占有最大的市场份额。然而,预计家庭护理领域在预测期内的复合年增长率最高。该细分市场的预计市场增长可归因于世界各地医院数量的增加以及外科手术数量的快速增长。
         < br>战略见解
从事疣治疗市场运营的公司正在采用产品创新战略来满足世界各地不断变化的客户需求,这也使他们能够在全球市场上保持自己的品牌声誉。

疣治疗市场 –按类型

  • 寻常疣
  • 生殖器疣
  • 扁平疣
  • 其他

疣治疗市场 –按治疗方法

  • 物理破坏
  • 冷冻疗法
  • 手术切除
  • 激光治疗
  • 免疫调节
    • 干扰素
    • 类维生素A
  • 化学破坏
      < li>博莱霉素
    • 斑蝥素
    • 水杨酸
    • 其他
  • 疣治疗市场–按最终用户划分

    • 医院
    • 家庭护理
    • 专科诊所
    • 其他

    疣治疗市场按地理位置

    • 北美洲
      • 美国
      • 加拿大
      • 墨西哥
    • < li>欧洲
      • 法国
      • 德国
      • 意大利
      • 英国
      • 西班牙
      • 休息欧洲
    • 亚太地区 (APAC)
      • 中国
      • 印度
      • 韩国
      • 日本
      • 澳大利亚
      • 亚太地区其他地区
    • 中东和非洲 (MEA)
      • 南非
      • 沙特阿拉伯
      • 阿联酋
      • MEA其他地区
    • 南美洲和中美洲(SCAM )
      • 巴西
      • 阿根廷
      • 其余骗局

     

    公司简介

    • Bausch Health Companies Inc.    
    • Nielsen BioSciences, Inc.    
    • Euro Vital Pharma GmbH    
    • Cipla Inc .     
    • Koninklijke Uterm&oml;hlen NV          
    • Novan, Inc.           
    • Scholl's Wellness Company          
    • 梯瓦制药工业有限公司          
    • Verrica Pharmaceuticals Inc.        
    • 葛兰素史克公司。          
    • AIM 免疫技术公司
    Report Coverage
    Report Coverage

    Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

    Segment Covered
    Segment Covered

    This text is related
    to segments covered.

    Regional Scope
    Regional Scope

    North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

    Country Scope
    Country Scope

    This text is related
    to country scope.

    Frequently Asked Questions


    What are warts therapeutics?

    Warts are skin growth caused by the human papillomavirus (HPV). There are more than 60 types of HPV, some of which tend to cause warts on the skin. Topical treatments could probably resolve the issue of warts in a few weeks with minimal side effects. Topical treatment of may not be effective all the time. Hence, cryotherapy with liquid nitrogen is a suitable option for treatment, where cure rate is 60% to 90% with less than 20% to 10% recurrence rate.

    What are the driving factors for the Warts Therapeutics market across the globe?

    The factors that are driving growth of the market are rising prevalence of human papillomavirus infections and recurrence of genital warts and new product developments.

    Who are the developments carrying out by major players in the warts therapeutics market?

    Various companies have made organic growth strategies in the warts therapeutics market. Some of the activities undertaken by the company, which have promoted its growth are, launches, enhancements and expansion & relocation activities. Companies such as Nielsen BioSciences, Inc, TEVA PHARMACEUTICAL INDUSTRIES LTD amongst others are some of the companies that have been implementing various organic strategies that have helped the growth of the company.

    Which region is dominated the warts therapeutics market?

    North America dominates the global warts therapeutics market due to factors such as rising prevalence of HPV, increasing product launches, well-developed healthcare facility centres equipped with modern-age equipment and instruments.

    Which segment is growing at the highest CAGR in the Warts Therapeutics market?

    The physical destruction segment is growing at the highest CAGR owing to availability of diagnostic devices and ease offered by these devices for diagnosis of various disorders.

    Which region is the fastest growing in the Warts Therapeutics market?

    Asia Pacific is expected to be the fastest growing region in the warts therapeutics market. The growth of the market in this region is primarily due to supportive government initiatives and research in the field of HPV infection.

    The List of Companies - Warts Therapeutics Market

    1. Bausch Health Companies Inc.            
    2. Nielsen BioSciences, Inc.        
    3. Euro Vital Pharma GmbH        
    4. Cipla Inc.       
    5. Koninklijke Utermöhlen NV      
    6. Novan, Inc.    
    7. Scholl's Wellness Company    
    8. TEVA PHARMACEUTICAL INDUSTRIES LTD               
    9. Verrica Pharmaceuticals Inc.    
    10. GlaxoSmithKline plc.              
    11. AIM ImmunoTech Inc

    The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

    1. Data Collection and Secondary Research:

    As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

    Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

    1. Primary Research:

    The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

    For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

    A typical research interview fulfils the following functions:

    • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
    • Validates and strengthens in-house secondary research findings
    • Develops the analysis team’s expertise and market understanding

    Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

    • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
    • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

    Below is the breakup of our primary respondents by company, designation, and region:

    Research Methodology

    Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

    1. Data Analysis:

    Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

    • Macro-Economic Factor Analysis:

    We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

    • Country Level Data:

    Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

    • Company Profile:

    The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

    • Developing Base Number:

    Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

    1. Data Triangulation and Final Review:

    The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

    We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

    We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

    Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

    Related Reports